134 related articles for article (PubMed ID: 29772243)
21. Alkynyloxy derivatives of 5,8-quinolinedione: Synthesis, in vitro cytotoxicity studies and computational molecular modeling with NAD(P)H:Quinone oxidoreductase 1.
Kadela-Tomanek M; Jastrzębska M; Pawełczak B; Bębenek E; Chrobak E; Latocha M; Książek M; Kusz J; Boryczka S
Eur J Med Chem; 2017 Jan; 126():969-982. PubMed ID: 28006669
[TBL] [Abstract][Full Text] [Related]
22. Synthesis, molecular properties and comparative docking and QSAR of new 2-(7-hydroxy-2-oxo-2H-chromen-4-yl)acetic acid derivatives as possible anticancer agents.
Elhenawy AA; Al-Harbi LM; El-Gazzar MA; Khowdiary MM; Moustfa A
Spectrochim Acta A Mol Biomol Spectrosc; 2019 Jul; 218():248-262. PubMed ID: 31003050
[TBL] [Abstract][Full Text] [Related]
23. Eco-friendly synthesis of novel cyanopyridine derivatives and their anticancer and PIM-1 kinase inhibitory activities.
Abouzid KAM; Al-Ansary GH; El-Naggar AM
Eur J Med Chem; 2017 Jul; 134():357-365. PubMed ID: 28431341
[TBL] [Abstract][Full Text] [Related]
24. Synthesis, Biological Evaluation and Docking Studies of Sorafenib Derivatives N-(3-fluoro-4-(pyridin-4-yloxy)phenyl)-4(5)-phenylpicolinamides.
Wang M; Wu C; Xu S; Zhu Y; Li W; Zheng P; Zhu W
Med Chem; 2017; 13(2):176-185. PubMed ID: 27855595
[TBL] [Abstract][Full Text] [Related]
25. Design, synthesis, anticancer, antimicrobial activities and molecular docking studies of theophylline containing acetylenes and theophylline containing 1,2,3-triazoles with variant nucleoside derivatives.
Ruddarraju RR; Murugulla AC; Kotla R; Chandra Babu Tirumalasetty M; Wudayagiri R; Donthabakthuni S; Maroju R; Baburao K; Parasa LS
Eur J Med Chem; 2016 Nov; 123():379-396. PubMed ID: 27487568
[TBL] [Abstract][Full Text] [Related]
26. Novel diphenylthiazole derivatives with multi-target mechanism: Synthesis, docking study, anticancer and anti-inflammatory activities.
Abdelazeem AH; El-Saadi MT; Said EG; Youssif BGM; Omar HA; El-Moghazy SM
Bioorg Chem; 2017 Dec; 75():127-138. PubMed ID: 28938224
[TBL] [Abstract][Full Text] [Related]
27. Synthesis and anti-tumour, immunomodulating activity of diosgenin and tigogenin conjugates.
Michalak O; Krzeczyński P; Cieślak M; Cmoch P; Cybulski M; Królewska-Golińska K; Kaźmierczak-Barańska J; Trzaskowski B; Ostrowska K
J Steroid Biochem Mol Biol; 2020 Apr; 198():105573. PubMed ID: 32017993
[TBL] [Abstract][Full Text] [Related]
28. Design, synthesis, and docking studies of quinazoline analogues bearing aryl semicarbazone scaffolds as potent EGFR inhibitors.
Tu Y; Wang C; Xu S; Lan Z; Li W; Han J; Zhou Y; Zheng P; Zhu W
Bioorg Med Chem; 2017 Jun; 25(12):3148-3157. PubMed ID: 28428040
[TBL] [Abstract][Full Text] [Related]
29. Synthesis, cytotoxic study and docking based multidrug resistance modulator potential analysis of 2-(9-oxoacridin-10(9H)-yl)-N-phenyl acetamides.
Kumar R; Kaur M; Bahia MS; Silakari O
Eur J Med Chem; 2014 Jun; 80():83-91. PubMed ID: 24769346
[TBL] [Abstract][Full Text] [Related]
30. Design, Synthesis and Docking Studies of Flavokawain B Type Chalcones and Their Cytotoxic Effects on MCF-7 and MDA-MB-231 Cell Lines.
Abu Bakar A; Akhtar MN; Mohd Ali N; Yeap SK; Quah CK; Loh WS; Alitheen NB; Zareen S; Ul-Haq Z; Shah SAA
Molecules; 2018 Mar; 23(3):. PubMed ID: 29518053
[TBL] [Abstract][Full Text] [Related]
31. Design, synthesis, and antitumor evaluation of quinoline-imidazole derivatives.
Xiao Z; Lei F; Chen X; Wang X; Cao L; Ye K; Zhu W; Xu S
Arch Pharm (Weinheim); 2018 Jun; 351(6):e1700407. PubMed ID: 29732607
[TBL] [Abstract][Full Text] [Related]
32. Synthesis, Molecular Docking, Molecular Dynamics Studies, and Biological Evaluation of 4H-Chromone-1,2,3,4-tetrahydropyrimidine-5-carboxylate Derivatives as Potential Antileukemic Agents.
Dolatkhah Z; Javanshir S; Sadr AS; Hosseini J; Sardari S
J Chem Inf Model; 2017 Jun; 57(6):1246-1257. PubMed ID: 28524659
[TBL] [Abstract][Full Text] [Related]
33. Synthesis, molecular docking and inhibition studies of novel 3-N-aryl substituted-2-heteroarylchromones targeting microtubule affinity regulating kinase 4 inhibitors.
Parveen I; Khan P; Ali S; Hassan MI; Ahmed N
Eur J Med Chem; 2018 Nov; 159():166-177. PubMed ID: 30290280
[TBL] [Abstract][Full Text] [Related]
34. Design, synthesis and biological evaluation of novel dual-acting modulators targeting both estrogen receptor α (ERα) and lysine-specific demethylase 1 (LSD1) for treatment of breast cancer.
He M; Ning W; Hu Z; Huang J; Dong C; Zhou HB
Eur J Med Chem; 2020 Jun; 195():112281. PubMed ID: 32283297
[TBL] [Abstract][Full Text] [Related]
35. Structure-based drug design, synthesis, In vitro, and In vivo biological evaluation of indole-based biomimetic analogs targeting estrogen receptor-α inhibition.
Hendy MS; Ali AA; Ahmed L; Hossam R; Mostafa A; Elmazar MM; Naguib BH; Attia YM; Ahmed MS
Eur J Med Chem; 2019 Mar; 166():281-290. PubMed ID: 30731397
[TBL] [Abstract][Full Text] [Related]
36. Synthesis, in vitro biological activities and in silico study of dihydropyrimidines derivatives.
Barakat A; Islam MS; Al-Majid AM; Ghabbour HA; Fun HK; Javed K; Imad R; Yousuf S; Choudhary MI; Wadood A
Bioorg Med Chem; 2015 Oct; 23(20):6740-8. PubMed ID: 26381063
[TBL] [Abstract][Full Text] [Related]
37. Anticancer effects of synthetic hexahydrobenzo [g]chromen-4-one derivatives on human breast cancer cell lines.
Pordeli M; Nakhjiri M; Safavi M; Ardestani SK; Foroumadi A
Breast Cancer; 2017 Mar; 24(2):299-311. PubMed ID: 27250840
[TBL] [Abstract][Full Text] [Related]
38. Synthesis, Molecular Docking Study and in vitro Anticancer Activity of Tetrazole Linked Benzochromene Derivatives.
Gorle S; Maddila S; Maddila SN; Naicker K; Singh M; Singh P; Jonnalagadda SB
Anticancer Agents Med Chem; 2017; 17(3):464-470. PubMed ID: 27357544
[TBL] [Abstract][Full Text] [Related]
39. Design, synthesis and antitumor activity of steroidal pyridine derivatives based on molecular docking.
Song YL; Tian CP; Wu Y; Jiang LH; Shen LQ
Steroids; 2019 Mar; 143():53-61. PubMed ID: 30590064
[TBL] [Abstract][Full Text] [Related]
40. Synthesis, cytotoxic evaluation, docking and in silico pharmacokinetic prediction of 4-arylideneamino/cycloalkylidineamino 1, 2-naphthoquinone thiosemicarbazones.
Shukla S; Srivastava RS; Shrivastava SK; Sodhi A; Kumar P
J Enzyme Inhib Med Chem; 2013 Dec; 28(6):1192-8. PubMed ID: 22978426
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
